FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Hokland

Research Profile

Disorders

Procedures

Physiology

DNA Methylation

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Trine Silkjaer; Anni Aggerholm; Lene Hyldahl Ebbesen; Peter Hokland; Eigil Kjeldsen; Jan Maxwell Nørgaard; Charlotte Guldborg Nyvold
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.
Kristiane Hornung Hamborg; Peter Hokland; Hans Herluf Nørregaard Bentzen; Lykke Grubach; Charlotte Guldborg Nyvold
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
Peter Hokland; Charlotte Guldborg Nyvold; Hans Beier Ommen; Anne Stidsholt Roug
Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Hokland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Trine Silkjaer; Anni Aggerholm; Lene Hyldahl Ebbesen; Peter Hokland; Eigil Kjeldsen; Jan Maxwell Nørgaard; Charlotte Guldborg Nyvold
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.
European journal of haematology 2013;90(5):385-96.
2012: Kristiane Hornung Hamborg; Peter Hokland; Hans Herluf Nørregaard Bentzen; Lykke Grubach; Charlotte Guldborg Nyvold
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
European journal of haematology 2012;89(5):385-94.
2012: Peter Hokland; Charlotte Guldborg Nyvold; Hans Beier Ommen; Anne Stidsholt Roug
Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation.
British journal of haematology 2012;158(5):569-80.
2012: Angela Y-C Tan; Andrew Wei; Stephen Q Wong; Dennis A Carney; Peter Hokland; Charlotte Guldborg Nyvold; John F Seymour; Alexander Dobrovic
Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.
Leukemia & lymphoma 2012;53(6):1225-9.
2012: Caroline Juhl-Christensen; Eigil Kjeldsen; Birgitte Lausen; Hans Beier Ommen; Anni Aggerholm; Henrik Hasle; Peter Hokland
Genetic and epigenetic similarities and differences between childhood and adult AML.
Pediatric blood & cancer 2012;58(4):525-31.
2012: Hans Beier Ommen; Anne Stidsholt Roug; Peter Hokland
The minimal residual disease concept coming of age - now for the direct comparison of methodologies.
Leukemia research 2012;36(4):392-3.
2011: Hanne Østergård Larsen; Katrine Nielsen; Anne Stidsholt Roug; Claus Svane Søndergaard; Peter Hokland
Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery.
Experimental hematology 2011;39(11):1081-9.
2011: Anne Stidsholt Roug; Susanne Schnittger; Mariann Christensen; Caroline Juhl-Christensen; Charlotte Guldborg Nyvold; Peter Hokland
A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
European journal of haematology 2011;87(5):461-3.
2011: M Østergaard; M T Andersen; D Grimwade; L Grubach; J V Jovanovic; Veli Kairisto; J K Larsen; Y G Morgan; Charlotte Guldborg Nyvold; U Ozbek; Niels Pallisgaard; H Pfeifer; S Schnittger; K Tobal; Peter Hokland
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.
Leukemia 2011;25(7):1168-73.
2011: Charlotte C Petersen; Line Nederby; Anne S Roug; Anni Skovbo; Niels A Peterslund; Peter Hokland; Bendt Nielsen; Marianne Hokland
Increased expression of CD69 on T cells as an early immune marker for human cytomegalovirus reactivation in chronic lymphocytic leukemia patients.
Viral immunology 2011;24(2):165-9.
2011: Peter Hokland; Hans Beier Ommen
Towards individualized follow-up in adult acute myeloid leukemia in remission.
Blood 2011;117(9):2577-84.
2010: Michael Grövdal; Mohsen Karimi; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Mette S Holm; Jon Magnus Tangen; Jonas Wallvik; Gunnar Oberg; Peter Hokland; Sten E Jacobsen; Anna Porwit; Eva Hellström-Lindberg
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
British journal of haematology 2010;150(3):293-302.
2010: Hans B Ommen; Mette Ostergaard; Ming Yan; Karin Braendstrup; Dong-Er Zhang; Peter Hokland
Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse.
European journal of haematology 2010;84(2):128-32.
2010: Hans Beier Ommen; Susanne Schnittger; Jelena V Jovanovic; Ingrid Beier Ommen; Henrik Hasle; Mette Østergaard; David Grimwade; Peter Hokland
Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
Blood 2010;115(2):198-205.
2009: Mike Zangenberg; Lykke Grubach; Anni Aggerholm; Trine Silkjaer; Caroline Juhl-Christensen; Charlotte Guldborg Nyvold; Eigil Kjeldsen; Hans Beier Ommen; Peter Hokland
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
European journal of haematology 2009;83(5):439-48.
2009: Peter Hokland; Hans Beier Ommen; Charlotte Guldborg Nyvold; Jesper Stentoft; Karin Braendstrup; Bodil Lind Andersen; Lone Siig Mikkelsen; Mette Ostergaard
[Minimal residual disease in malignant diseases of the blood II. Translation and therapeutic consequences].
Ugeskrift for laeger 2009;171(4):232-5.
2009: Peter Hokland; Charlotte Guldborg Nyvold; Jesper Stentoft; Hans Beier Ommen; Lene Hyldahl Ebbesen; Karin Braendstrup; Bodil Lind Andersen; Lone Siig Mikkelsen; Mette Ostergaard
[Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation].
Ugeskrift for laeger 2009;171(4):229-31.
2008: Caroline Juhl-Christensen; Marianne Bomberg; Dorte Melsvik; Peter Hokland; Charlotte Guldborg Nyvold
Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.
European journal of haematology 2008;81(4):273-80.
2008: Lykke Grubach; Caroline Juhl-Christensen; Anita Rethmeier; Lene Hyldahl Olesen; Anni Aggerholm; Peter Hokland; Mette Ostergaard
Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia.
European journal of haematology 2008;81(2):112-22.
2008: Hans Beier Ommen; Charlotte Guldborg Nyvold; Karin Braendstrup; Bodil Lind Andersen; Ingrid Beier Ommen; Henrik Hasle; Peter Hokland; Mette Ostergaard
Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
British journal of haematology 2008;141(6):782-91.
2008: Kirsten Grønbaek; Ulrik Ralfkiaer; Christina Dahl; Christoffer Hother; Jorge Burns; Moustapha Kassem; Jesper Worm; Elisabeth Ralfkiaer; Lene M Knudsen; Peter Hokland; Per Guldberg
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(5):632-8.
2008: Ingelise Bjerring Kastrup; Jesper Worm; Elisabeth Ralfkiaer; Peter Hokland; Per Guldberg; Kirsten Grønbaek
Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
European journal of haematology 2008;80(1):61-6.
2007: Michael Grövdal; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Jonas Wallvik; Jon Magnus Tangen; Gunnar Oberg; Sten Eirik W Jacobsen; Peter Hokland; Anna Porwit; Eva Hellström-Lindberg
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7107-12.
2007: Charlotte Guldborg Nyvold; Knud Bendix; Margrethe Brandsborg; Stanislaw Pulczynski; Trine Silkjaer; Peter Hokland
Multiplex PCR for the detection of BCL-1/IGH and BCL-2/IGH gene rearrangements--clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 2007;46(1):21-30.
2006: Charlotte Guldborg Nyvold; Jesper Stentoft; K Braendstrup; D Melsvik; S K Moestrup; C Juhl-Christensen; Henrik Hasle; Peter Hokland
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications.
Leukemia 2006;20(11):2051-4.
2006: Anita Rethmeier; Anni Aggerholm; Lene Hyldahl Olesen; Caroline Juhl-Christensen; Charlotte Guldborg Nyvold; Per Guldberg; Peter Hokland
Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
British journal of haematology 2006;133(3):276-83.
2006: Henrik Hasle; Bendik Lund; Charlotte Guldborg Nyvold; Peter Hokland; Mette Østergaard
WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
Leukemia research 2006;30(5):543-6.
2006: Jesper Stentoft; Peter Hokland; Mette Ostergaard; Henrik Hasle; Charlotte Guldborg Nyvold
Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.
Leukemia research 2006;30(4):389-95.
2006: Rasheed Khan; Anni Aggerholm; Peter Hokland; Moustapha Hassan; Eva Hellström-Lindberg
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
Experimental hematology 2006;34(1):35-43.
2006: Anni Aggerholm; Mette S Holm; Per Guldberg; Lene Hyldahl Olesen; Peter Hokland
Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
European journal of haematology 2006;76(1):23-32.
2005: Lene Hyldahl Olesen; Anni Aggerholm; Bodil Lind Andersen; Charlotte Guldborg Nyvold; Per Guldberg; Jan Maxwell Nørgaard; Peter Hokland
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.
British journal of haematology 2005;131(4):457-67.
2005: Lene Hyldahl Olesen; Charlotte Guldborg Nyvold; Anni Aggerholm; Jan Maxwell Nørgaard; Per Guldberg; Peter Hokland
Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
European journal of haematology 2005;75(3):185-92.
2005: Anders Castor; Lars Nilsson; Ingbritt Astrand-Grundström; Miranda Buitenhuis; Carole Ramirez; Kristina Anderson; Bodil Strömbeck; Stanislaw Garwicz; Albert N Békássy; Kjeld Schmiegelow; Birgitte Lausen; Peter Hokland; Sören Lehmann; Gunnar Juliusson; Bertil Johansson; Sten Eirik W Jacobsen
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
Nature medicine 2005;11(6):630-7.
2005: Claus L Andersen; Alicja M Gruszka-Westwood; Shayne Atkinson; Estella Matutes; Daniel Catovsky; Rikke K Pedersen; Bjarne B Pedersen; Stanislaw Pulczynski; Peter Hokland; Elisa Jacobsen; Jørn Koch
Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization.
Cancer genetics and cytogenetics 2005;156(2):122-8.
2004: Mette Østergaard; Jesper Stentoft; Peter Hokland
A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.
Leukemia research 2004;28(11):1213-5.
2004: Lene Hyldahl Olesen; Niels Clausen; Andreja Dimitrijevic; Gitte B Kerndrup; Eigil Kjeldsen; Peter Hokland
Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
British journal of haematology 2004;127(1):59-66.
2004: Mette Østergaard; Lene Hyldahl Olesen; Henrik Hasle; Eigil Kjeldsen; Peter Hokland
WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
British journal of haematology 2004;125(5):590-600.
2004: K B Petersen; Peter Hokland; G B Petersen; Charlotte Guldborg Nyvold; K Brorson Petersen; G Bruun Petersen; C Guldborg Nyvold
Erythropoietin receptor defect: a cause of primary polycythaemia.
British journal of haematology 2004;125(4):537-8.
2004: Jan Maxwell Nørgaard; Lene Hyldahl Olesen; Peter Hokland
Changing picture of cellular drug resistance in human leukemia.
Critical reviews in oncology/hematology 2004;50(1):39-49.
2003: Peter Hokland
[Stem cell differentiation--significance of new findings for transplantation biology].
Ugeskrift for laeger 2003;165(50):4840-3.
2003: Emmanuel Beillard; N Pallisgaard; V H J van der Velden; W Bi; R Dee; E van der Schoot; Eric Delabesse; Elizabeth Macintyre; Enrico Gottardi; Giuseppe Saglio; Franz Watzinger; Thomas Lion; Jacques J M van Dongen; Peter Hokland; Jean Gabert
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Leukemia 2003;17(12):2474-86.
2003: Lene Hyldahl Olesen; Jan Maxwell Nørgaard; N Pallisgaard; A Bukh; Peter Hokland
Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.
European journal of haematology 2003;70(5):296-303.
2002: Lisa Lyngsie Hjalgrim; Hans O Madsen; Mads Melbye; Poul Jørgensen; Michael Christiansen; M T Andersen; N Pallisgaard; Peter Hokland; Niels Clausen; lars peter ryder; Kjeld Schmiegelow; Henrik Hjalgrim
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
British journal of cancer 2002;87(9):994-9.
2002: Kirsten Grønbaek; Jesper Worm; Elisabeth Ralfkiaer; Vibeke Ahrenkiel; Peter Hokland; Per Guldberg
ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Blood 2002;100(4):1430-7.
2002: Lars Nilsson; Ingbritt Astrand-Grundström; Kristina Anderson; Ingrid Arvidsson; Peter Hokland; David Bryder; Lars Kjeldsen; Bertil Johansson; Eva Hellström-Lindberg; Robert Hast; Sten Eirik W Jacobsen
Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Blood 2002;100(1):259-67.
2002: Bettina Dencker Hansen; Mogens Duch; Peter Hokland; Finn Skou Pedersen; Marianne Hokland
Quantitative evaluation of the murine B16 melanoma tumor model after gene marking with an EGFP/Neo expressing retroviral vector.
In vivo (Athens, Greece) 2002;16(3):167-74.
2002: Judith L Autrup; Peter Hokland; Lars Pedersen; Herman Autrup
Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia.
European journal of pharmacology 2002;438(1-2):15-8.
2002: Gitte Olesen; Hanne Tønder; Torben Palshof; Peter Hokland
Peripheral blood accessory cells modulate committed colony-forming units but not 5-week cobblestone-area-forming cell outgrowth from CD34+ cells.
European journal of haematology 2002;68(2):65-72.
2001: Jesper Stentoft; N Pallisgaard; Eigil Kjeldsen; Mette S Holm; Johan Lanng Nielsen; Peter Hokland
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction.
European journal of haematology 2001;67(5-6):302-8.
2001: Jan Maxwell Nørgaard; Lene Hyldahl Olesen; Gitte Olesen; K Meyer; Jørgen S Kristensen; Knud Bendix; Bent Pedersen; Eigil Kjeldsen; Peter Hokland
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.
European journal of haematology 2001;67(4):221-9.
2001: Peter Hokland; N Pallisgaard
[Molecular biology in acute lymphoblastic leukemia].
Ugeskrift for laeger 2001;163(35):4721-4.
2001: fatih uckun; N Pallisgaard; Peter Hokland; Christopher S Navara; Rama Krishna Narla; Paul S Gaynon; Harland Sather; Nyla A Heerema
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;42(1-2):41-56.
2001: M T Andersen; I Nordentoft; Lisa Lyngsie Hjalgrim; C L Christiansen; V D Jakobsen; Henrik Hjalgrim; N Pallisgaard; Hans O Madsen; Michael Christiansen; lars peter ryder; Niels Clausen; Peter Hokland; Kjeld Schmiegelow; Mads Melbye; Poul Jørgensen
Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia.
Leukemia 2001;15(5):858-9.
2001: Jan Maxwell Nørgaard; S T Langkjer; Torben Palshof; Bent Pedersen; Peter Hokland
Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia.
European journal of haematology 2001;66(3):160-7.
2001: Gitte Olesen; Hanne Tønder; Mette S Holm; Peter Hokland
Long-term culture of hematopoietic stem cells - validating the stromal component of the CAFC assay.
Cytotherapy 2001;3(2):107-16.
2000: Jan Maxwell Nørgaard; Peter Hokland
Biology of multiple drug resistance in acute leukemia.
International journal of hematology 2000;72(3):290-7.
2000: Peter Hokland; N Pallisgaard
Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia.
Seminars in hematology 2000;37(4):358-67.
2000: Anni Aggerholm; Kirsten Grønbaek; Per Guldberg; Peter Hokland
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
European journal of haematology 2000;65(2):109-13.
2000: B Simonsson; TH Tötterman; Peter Hokland; F Lauria; A M Carella; M N Fernandez; C Rozman; A Ferrant; T de Witte; A R Zander; K Meier; F Hansson; B I Nilsson
Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.
Bone marrow transplantation 2000;25(11):1121-7.
2000: Anni Aggerholm; Peter Hokland
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?
Blood 2000;95(9):2997-9.
2000: Mette S Holm; Gitte Olesen; K Meyer; Peter Hokland
[Hematopoietic stem cells II. Diagnostic and therapeutic aspects].
Ugeskrift for laeger 2000;162(3):313-7.
2000: Gitte Olesen; Mette S Holm; Peter Hokland
[Hematopoietic stem cells I. Basal aspects].
Ugeskrift for laeger 2000;162(3):309-13.
2000: Gitte Olesen; Hanne Tønder; Peter Hokland
Reduced total number of cobblestone area forming cells and in vitro stromal-cell growth in autografts from acute myeloid leukemia patients.
Cytotherapy 2000;2(3):201-9.
1999: N Pallisgaard; Niels Clausen; H Schroder; Peter Hokland
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript.
Genes, chromosomes & cancer 1999;26(4):355-65.
1999: Marianne Hokland; H Jørgensen; Mette S Holm; B Simonsson; B Nilsson; M Bengtsson; Peter Hokland
Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation.
European journal of haematology 1999;63(4):251-8.
1999: Jan Maxwell Nørgaard; Gitte Olesen; Jørgen S Kristensen; Bent Pedersen; Peter Hokland
Leukaemia cell drug resistance and prognostic factors in AML.
European journal of haematology 1999;63(4):219-24.
1999: M Holm; M Thomsen; Morten Høyer; Peter Hokland
Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood.
British journal of haematology 1999;105(4):1002-13.
1999: Marianne Hokland; Jorgen Kjaergaard; Peter Kuppen; Ulf Nannmark; Ralf Agger; Peter Hokland; Per H Basse
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
In vivo (Athens, Greece) 1999;13(3):199-204.
1999: Anni Aggerholm; Per Guldberg; M Hokland; Peter Hokland
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia.
Cancer research 1999;59(2):436-41.
1998: Peter Hokland; M Hokland
[How natural are natural products?].
Ugeskrift for laeger 1998;160(51):7448-9.
1998: I Hansen; K Meyer; Peter Hokland
Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens.
European journal of haematology 1998;61(5):339-46.
1998: Peter Hokland; Bent Pedersen; Knud Bendix; J E Koch; N Pallisgaard
[Multidisciplinary diagnostics in acute leukemia].
Ugeskrift for laeger 1998;160(38):5473-8.
1998: N Pallisgaard; Peter Hokland; D C Riishøj; Bent Pedersen; Poul Jørgensen
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia.
Blood 1998;92(2):574-88.
1998: Jorgen Kjaergaard; Marianne Hokland; Ulf Nannmark; Peter Hokland; Per H Basse
Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy.
Scandinavian journal of immunology 1998;47(6):532-40.
1998: Per Guldberg; K Grønbak; Anni Aggerholm; A Platz; Per thor Straten; Vibeke Ahrenkiel; Peter Hokland; Jesper Zeuthen
Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis.
Nucleic acids research 1998;26(6):1548-9.
1998: Peter Hokland; I Carlsen; Marianne Hokland; B Nielsen
Modulatory function on autologous myeloid progenitor cells of clonal T-lymphocytes following autologous bone marrow transplantation.
European journal of haematology 1998;60(3):189-96.
1998: Jan Maxwell Nørgaard; A Bukh; S T Langkjer; Niels Clausen; Torben Palshof; Peter Hokland
MDR1 gene expression and drug resistance of AML cells.
British journal of haematology 1998;100(3):534-40.
1998: Gitte Olesen; I Carlsen; A Skovbo; Marianne Hokland; Peter Hokland
Delineation of erythropoiesis in normal and malignant bone marrow using monoclonal antibody AS-E1 directed against transferrin receptors (CD71).
European journal of haematology 1998;60(1):53-60.
1997: B Hjorth-Sørensen; N Pallisgaard; Mikaela Grönholm; Peter Hokland; Niels Clausen; Poul Jørgensen
A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method.
Leukemia 1997;11(9):1588-93.
1996: H Jørgensen; A Bukh; Peter Hokland; J Ellegaard; P S Madsen; Marianne Hokland
[Diagnosis of minimal residual disease in autologous bone marrow transplantation].
Nordisk medicin 1996;111(10):344-7.
1996: H Jørgensen; Peter Hokland; A W Jensen; Marianne Hokland
Little evidence for clonal evolution of malignant haematopoietic cells following relapse after autologous bone marrow transplantation.
European journal of haematology 1996;57(1):25-32.
1996: Jan Maxwell Nørgaard; S T Langkjer; Torben Palshof; Niels Clausen; B Pedersen; Peter Hokland
Relation of blast cell survival and proliferation to chemotherapy resistance in AML.
British journal of haematology 1996;93(4):888-97.
1995: I M Jensen; P D Jensen; M E Hokland; Peter Hokland; J Ellegaard
[Erythropoiesis in myelodysplastic syndrome detected by multiparameter flow cytometry].
Ugeskrift for laeger 1995;157(37):5092-6.
1995: P S Madsen; Peter Hokland; N Clausen; J Ellegaard; Marianne Hokland
Differential expression levels of the heat shock protein 27 isoforms in pediatric normal, nonleukemic and common acute lymphoblastic leukemia B-cell precursors.
Blood 1995;85(2):510-21.
1995: H Jorgensen; Peter Hokland; T Jensen; Per H Basse; Marianne Hokland
Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
Natural immunity 1995;14(3):164-72.
1994: Poul Henning Jensen; L I Cressey; Bjorn T Gjertsen; P Madsen; Gunnar Mellgren; Peter Hokland; Jørgen Gliemann; Stein Ove Døskeland; Michel Lanotte; Olav Karsten Vintermyr
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis.
British journal of cancer 1994;70(5):834-40.
1994: B Nielsen; Peter Hokland
Clonal T-lymphocytes from untreated hairy-cell leukaemia patients enhance the growth of BFU-E.
European journal of haematology 1994;53(5):271-9.
1994: I M Jensen; Peter Hokland
The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry.
British journal of haematology 1994;87(3):477-82.
1993: A Tolstrup; Peter Hokland; B Nielsen; Just Justesen; Marianne Hokland
Expression and regulation of an interferon-alpha-inducible membrane protein p106 on human hematopoietic cells.
Journal of interferon research 1993;13(6):433-41.
1993: I M Jensen; J Ellegaard; Peter Hokland
Differences in relative DNA content between human peripheral blood and bone marrow subpopulations--consequences for DNA index calculations.
Cytometry 1993;14(8):936-42.
1993: I M Jensen; M Hokland; Peter Hokland
A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry.
Leukemia research 1993;17(10):839-46.
1993: Jan Maxwell Nørgaard; S T Langkjer; J Ellegaard; Torben Palshof; Niels Clausen; Peter Hokland
Synergistic and antagonistic effects of myeloid growth factors on in vitro cellular killing by cytotoxic drugs.
Leukemia research 1993;17(8):689-94.
1993: I M Jensen; J S Kristensen; M Thomsen; J Ellegaard; Peter Hokland
Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1993;5(4):213-23.
1993: B Nielsen; Peter Hokland
Mononuclear cells from peripheral blood of untreated hairy-cell leukaemia patients enhance the growth of BFU-e.
European journal of haematology 1993;50(4):222-7.
1992: P Jessen; B Nielsen; I M Jensen; J Ellegaard; Peter Hokland
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation].
Ugeskrift for laeger 1992;154(52):3754-7.
1992: Peter Hokland; Christian Hartmann Geisler; E Andersen; A Drivsholm; MM Hansen; K Meyer
Mouse erythrocyte rosette formation with malignant human B-lymphocytes re-evaluated: still a useful marker for differentiating mature B-cell malignancies.
British journal of haematology 1992;82(3):560-4.
1992: P S Madsen; B Nielsen; A W Jensen; Just Justesen; J Ellegaard; Peter Hokland; Marianne Hokland
Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study.
Journal of interferon research 1992;12(5):345-53.
1992: B Nielsen; P S Madsen; A W Jensen; Peter Hokland; Marianne Hokland
Interferon-alpha-induced changes in surface antigens in a hairy-cell leukemia (JOK-1), and a Burkitt's lymphoma cell line (Daudi) during in vitro culture.
European journal of haematology 1992;48(3):146-51.
1992: J S Kristensen; A W Jensen; I M Jensen; B Pedersen; J Ellegaard; Peter Hokland
Hybrid acute leukemia: therapeutical implications of immunological phenotyping.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1992;4(2):69-79.
1992: A W Jensen; Peter Hokland; J S Kristensen; Just Justesen; Marianne Hokland
Evolution of Ig- and T-cell receptor gene configuration in a Ph1+ hybrid leukemia patient.
European journal of haematology 1992;48(2):105-9.
1992: Søren K Moestrup; Peter Hokland
Surface expression of the alpha 2-macroglobulin receptor on human malignant blood cells.
Leukemia research 1992;16(3):227-34.
1991: A W Jensen; Marianne Hokland; H Jørgensen; Just Justesen; J Ellegaard; Peter Hokland
Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis.
Blood 1991;78(5):1292-300.
1991: I M Jensen; P D Jensen; J Ellegård; P Bastrup-Madsen; Peter Hokland
[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)].
Ugeskrift for laeger 1991;153(16):1125-9.
1991: B Nielsen; P Jessen; Peter Hokland
Regulation of autologous T-lymphocyte clones on in vitro growth of BFU-e: enhancing effects of both CD4- and CD8-positive clones.
European journal of haematology 1991;46(1):26-32.
1991: J S Kristensen; Peter Hokland
Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
Leukemia research 1991;15(8):693-700.
1991: A W Jensen; Peter Hokland; H Jørgensen; Just Justesen; Marianne Hokland
[Current therapeutic targeting possibilities in leukemia].
Nordisk medicin 1991;106(12):336-9.
1990: J S Kristensen; Peter Hokland
Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes.
British journal of haematology 1990;74(3):270-6.
1990: Robert Zachariae; J S Kristensen; Peter Hokland; J Ellegaard; E Metze; Marianne Hokland
Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects. An overview.
Psychotherapy and psychosomatics 1990;54(1):32-9.
1989: S Pulczynski; A M Boesen; O M Jensen; J Ellegaard; Peter Hokland
Immunoelectron microscopy studies on the modulation of common acute lymphoblastic leukemia antigen (CALLA) on NALM-6 cells: delineation of intracellular transport.
Leukemia 1989;3(2):137-44.
1989: B Nielsen; Marianne Hokland; Just Justesen; H Hasselbalch; J Ellegaard; Peter Hokland
Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
European journal of haematology 1989;42(1):50-9.
1989: B Nielsen; Peter Hokland; J Ellegaard; H Hasselbalch; Marianne Hokland
Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Leukemia research 1989;13(6):451-6.
1988: G Kerndrup; K Bendix-Hansen; B Pedersen; J Ellegaard; Peter Hokland
Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data.
European journal of haematology 1988;41(4):368-74.
1988: P S Madsen; Marianne Hokland; J Ellegaard; Peter Hokland; G P Ratz; Ariana Celis; Julio E Celis
Major proteins in normal human lymphocyte subpopulations separated by fluorescence-activated cell sorting and analyzed by two-dimensional gel electrophoresis.
Leukemia 1988;2(9):602-15.
1988: G Kerndrup; Peter Hokland
Natural killer cell-mediated inhibition of bone marrow colony formation (CFU-GM) in refractory anaemia (preleukaemia): evidence for patient-specific cell populations.
British journal of haematology 1988;69(4):457-62.
1988: Jørgen S Kristensen; J Ellegaard; K B Hansen; N Clausen; Peter Hokland
First-line diagnosis based on immunological phenotyping in suspected acute leukemia: a prospective study.
Leukemia research 1988;12(9):773-82.
1987: J S Kristensen; J Ellegaard; Peter Hokland
A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies.
Blood 1987;70(4):1063-8.
1987: G Kerndrup; K Bendix-Hansen; B Pedersen; J Ellegaard; Peter Hokland
13-cis retinoic acid treatment of myelodysplastic syndromes.
Leukemia research 1987;11(1):7-16.
1986: G Kerndrup; K Bendix-Hansen; B Pedersen; J Ellegaard; Peter Hokland
Primary myelodysplastic syndrome: treatment of 6 patients with 13-cis retinoic acid.
Scandinavian journal of haematology. Supplementum 1986;45():128-32.
1980: Peter Hokland; I Heron
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood.
Scandinavian journal of immunology 1980;11(3):353-6.